跳至主要内容
临床试验/CTRI/2021/10/037434
CTRI/2021/10/037434尚未招募未知

Prognostic role of Mid-Range Proadenomedullin in patients undergoing Emergency Laparotomy for Intestinal Perforation: A Pilot Study - MR ProADM

AIIMS Rishikesh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • All patients, both male and female, aged 20 to 80 years, undergoing emergency laparotomy for intestinal perforation under general anesthesia

排除标准

  • 1.Presence of diagnosis of cystic fibrosis, congestive heart failure, respiratory failure, renal failure, cirrhosis and cancer.
  • 2.An immunocompromising condition will be defined as one of the following:
  • 1.Human immunodeficiency virus (HIV) infection
  • 2.Neutropenia ( <500 neutrophils/mm3)
  • 3.Active chemotherapy within the 3 months preceding eligibility or immunosuppressive therapy after organ transplantation.

研究者

相似试验